UT Health San Antonio obtained $64,848,287 in FY19 from the National Institutes of Health, Department of Defense, industry, and philanthropy to support multi-disciplinary research, teaching, and outreach programs.
UT Health San Antonio patented a discovery in protection against traumatic brain injury.
UT Health San Antonio is home to the Biggs Institute for Alzheimer and Neurodegenerative Diseases, dedicated to clinical research on Alzheimer’s.
UT Health is a leader in translational research studies on neurodegenerative diseases. We take research from the lab into clinical settings to understand the disease process in the brain and explore innovative ways to intervene and slow or stop disease.
Because of the increase in life expectancy and aging of the population, health care systems will likely see an increase in the number of patients with brain hemorrhages, said Dr. Seshadri, who is senior investigator of the Framingham Heart Study and at UT Health San Antonio directs the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases.
UT Health San Antonio and University Health System are conducting a research study to learn which of two strategies for monitoring and treating patients with severe traumatic brain injury in the intensive
care unit (ICU) is more likely to help them get better. Both strategies are used in standard care. It is unknown if one is more effective than the other.
Instead of focusing on how to cure the disease, as is the focus of most Alzheimer's research, Dr. Frost's team looked at what causes the disease. In doing so, her team was able to identify targets that can mitigate the spread of toxic proteins in the brain.